During the past decade, Newtown Clinical Research conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 7 clinical trials were completed, i.e. on average, 43.8% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Newtown Clinical Research" #1 sponsor was "BioNTech SE" with 3 trials, followed by "Celldex Therapeutics" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Shire" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Newtown Clinical Research" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Medical Research Council, South Africa" with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Newtown Clinical Research" are "COVID-19" (6 trials), "SARS-CoV-2 Infection" (3 trials), "Influenza A" (2 trials), "Adenoviral Conjunctivitis" (1 trials) and "Bacterial Conjunctivitis" (1 trials). Many other conditions were trialed in "Newtown Clinical Research" in a lesser frequency.

Most popular intervention types in "Newtown Clinical Research" are "Drug" (12 trials), "Biological" (8 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "BNT162b2" (3 trials), "Matching Placebo" (2 trials), "PVP-I 0.6%" (2 trials) and "SHP640" (2 trials). Other intervention names were less common.

The vast majority of trials in "Newtown Clinical Research" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Newtown Clinical Research". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Newtown Clinical Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Newtown Clinical Research, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".